Agata Rozanska

822 citations
16 papers · 611 indexed · h-index 14

Agata Rozanska

16 papers receiving 610 citations

Peers

Agata Rozanska
Comparison fields: 5 of 51
  • Clinical Biochemistry 68
  • Molecular Biology 556
  • Oncology 113
  • Cancer Research 45
  • Ophthalmology 21
Replace Pablo Villavicencio‐Lorini with:
Pablo Villavicencio‐Lorini Germany
D. Perucca‐Lostanlen France
Melinda M. DiVito United States
Béryl Royer‐Bertrand Switzerland
Federica Polato United States
Juergen Hench Switzerland
Diederik de Bruijn Netherlands
Nagasamy Soumittra India
Bert Eussen Netherlands
Deborah Pajalunga Italy
Agata Rozanska relative to Pablo Villavicencio‐Lorini Germany Pablo Villavicencio‐Lorini's profile →
Citations per field
00.5×5.2×
Pablo Villavicencio‐Lorini · 1×
Citations per year

Countries citing papers authored by Agata Rozanska

Since Specialization
Citations

This map shows the geographic impact of Agata Rozanska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agata Rozanska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agata Rozanska more than expected).

Fields of papers citing papers by Agata Rozanska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agata Rozanska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agata Rozanska. The network helps show where Agata Rozanska may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Agata Rozanska, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Agata Rozanska Line = papers co-authored together Agata Rozanska links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 202416
2 202413
3 20231
4 202222
5 20211
6 201773
7 201735
8 201640
9 201453
10 201443
11 201374
12 201118
13 201047
14 201016
15 201098
16 200961

About Agata Rozanska

Agata Rozanska is a scholar working on Ophthalmology, Molecular Biology and Clinical Biochemistry, having authored 16 papers that have together received 611 indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (8 papers), RNA modifications and cancer (7 papers), Mitochondrial Function and Pathology (6 papers), Retinal Development and Disorders (5 papers), Retinal Diseases and Treatments (3 papers), Ocular Oncology and Treatments (3 papers), RNA Research and Splicing (3 papers) and Single-cell and spatial transcriptomics (2 papers). The work is most often cited by research in Clinical Biochemistry (68 citations), Molecular Biology (556 citations) and Oncology (113 citations). Agata Rozanska has collaborated with scholars based in United Kingdom, Israel and Australia. Frequent co-authors include Zofia M. Chrzanowska‐Lightowlers, Robert N. Lightowlers, Sven Dennerlein, Mateusz Wydro, Marine Beinat, Arnold Münnich, Valérie Serre, Nathalie Boddaert, Deborah A. Tweddle and Elizabeth Ruth Plummer. Their work appears in journals such as Biochemical Journal, Nucleic Acids Research, Experimental Eye Research, Clinical Cancer Research and iScience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026